Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

doi:10.1016/j.metabol.2020.154244

科研成果详情

题名	Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
作者	Kenneth I Zheng 1; Feng Gao2; Xiao-Bo Wang 3; Qing-Feng Sun 4; Ke-Hua Pan5; Ting-Yao Wang 6; Hong-Lei Ma 1; Yong-Ping Chen1; Wen-Yue Liu7; Jacob George 8; Ming-Hua Zheng9
发表日期	2020-07-01
发表期刊	Metabolism: clinical and experimental 影响因子和分区
语种	英语
原始文献类型	Article
关键词	COVID-19 MAFLD Obesity SARS-CoV-2.
出版者	W B SAUNDERS CO-ELSEVIER INC
ISSN	0026-0495
EISSN	1532-8600
卷号	108 页码:154244
DOI	10.1016/j.metabol.2020.154244
页数	3
WOS类目	Endocrinology & Metabolism
WOS研究方向	Endocrinology & Metabolism
WOS记录号	WOS:000542550800005
收录类别	PUBMED ; SCOPUS ; SCIE
URL	查看原文
PubMed ID	32320741
PMC记录号	PMC7166301
SCOPUSEID	2-s2.0-85083900952
通讯作者地址	[Zheng, Ming-Hua]Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, 2 Fuxue Lane, Wenzhou 325000, Peoples R China. ; [George, Jacob]Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW 2145, Australia. ; [George, Jacob]Univ Sydney, Westmead, NSW 2145, Australia.
TOP期刊	TOP期刊
引用统计	被引频次：190[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/33439
专题	附属第一医院附属第一医院_肾内科第一临床医学院（信息与工程学院）、附属第一医院_影像医学与核医学_放射科
作者单位	1.MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 2.Department of Gastroenterology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 3.Department of Critical Care Medicine, Wenzhou Central Hospital, Wenzhou, China.; 4.Department of Infectious Diseases, Ruian People&s Hospital, Wenzhou, China.; 5.Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 6.Department of Nephrology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 7.Department of Endocrinology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 8.Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, Australia. Electronic address: jacob.george@sydney.edu.au.; 9.MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Institute of Hepatology, Wenzhou Medical University, Wenzhou, China; Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China.
第一作者单位	附属第一医院; 第一临床医学院（信息与工程学院）、附属第一医院
通讯作者单位	附属第一医院
第一作者的第一单位	附属第一医院
推荐引用方式 GB/T 7714	Kenneth I Zheng,Feng Gao,Xiao-Bo Wang,et al. Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease[J]. Metabolism: clinical and experimental,2020,108:154244.
APA	Kenneth I Zheng., Feng Gao., Xiao-Bo Wang., Qing-Feng Sun., Ke-Hua Pan., ... & Ming-Hua Zheng. (2020). Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism: clinical and experimental, 108, 154244.
MLA	Kenneth I Zheng,et al."Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease".Metabolism: clinical and experimental 108(2020):154244.